RSS for Daniel E. Caseyhttp://academic.research.microsoft.com/Rss.aspx?id=23862906Search RSS feed for Microsoft Academic SearchMSRA Libra RSS Burner(c)2008 Microsoft Corpration, All right reserved.Wed, 19 Jun 2013 13:28:28 GMTWed, 19 Jun 2013 13:28:28 GMTDaniel E. Casey (Personal Info) http://academic.research.microsoft.com/Author/23862906Wed, 19 Jun 2013 13:28:28 GMTOregon Health & Science University

Publications: 68

Citation Count: 1614

G-index: 39

Field Rating: 22

Fields of study: Psychiatry & Psychology, Pharmacology, Cardiology

Homepage:

Permanent Link: http://academic.research.microsoft.com/Author/23862906

]]>238645882239Oregon Health & Science University2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicinehttp://academic.research.microsoft.com/Publication/33536292Wed, 19 Jun 2013 13:28:28 GMT2386290633536292L. F. Hiratzka, G. L. Bakris, J. A. Beckman, R. M. Bersin, V. F. Carr, D. E. Casey, K. A. Eagle, L. K. Hermann, E. M. Isselbacher, E. A. Kazerooni, N. T. Kouchoukos, B. W. Lytle, D. M. Milewicz, D. L. Reich, S. Sen, J. A. Shinn, L. G. Svensson, D. M. Williams

Circulation, vol. 121, no. 13, pp. e266-e369, 2010

(Citations:27)

]]>2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicinehttp://academic.research.microsoft.com/Publication/33536492Wed, 19 Jun 2013 13:28:27 GMT2386290633536492L. F. Hiratzka, G. L. Bakris, J. A. Beckman, R. M. Bersin, V. F. Carr, D. E. Casey, K. A. Eagle, L. K. Hermann, E. M. Isselbacher, E. A. Kazerooni, N. T. Kouchoukos, B. W. Lytle, D. M. Milewicz, D. L. Reich, S. Sen, J. A. Shinn, L. G. Svensson, D. M. Williams

Circulation, vol. 121, no. 13, pp. 1544-1579, 2010

(Citations:2)

]]>Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mousehttp://academic.research.microsoft.com/Publication/49335314Wed, 19 Jun 2013 13:28:26 GMT2386290649335314G. S. Dawe, R. Nagarajah, R. Albert, D. E. Casey, K. W. Gross, A. K. Ratty

Neuroscience, vol. 171, no. 1, pp. 162-172, 2010

]]>2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantationhttp://academic.research.microsoft.com/Publication/33518317Wed, 19 Jun 2013 13:28:25 GMT2386290633518317M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, M. A. Silver, L. W. Stevenson, C. W. Yancy

Circulation, vol. 119, no. 14, pp. 1977-2016, 2009

(Citations:161)

]]>2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelineshttp://academic.research.microsoft.com/Publication/33528945Wed, 19 Jun 2013 13:28:24 GMT2386290633528945F. G. Kushner, M. Hand, S. C. Smith, S. B. King, J. L. Anderson, E. M. Antman, S. R. Bailey, E. R. Bates, J. C. Blankenship, D. E. Casey, L. A. Green, J. S. Hochman, A. K. Jacobs, H. M. Krumholz, D. A. Morrison, J. P. Ornato, D. L. Pearle, E. D. Peterson, M. A. Sloan, P. L. Whitlow, D. O. Williams

Circulation, vol. 120, no. 22, pp. 2271-2306, 2009

(Citations:16)

]]>Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophreniahttp://academic.research.microsoft.com/Publication/37044385Wed, 19 Jun 2013 13:28:23 GMT2386290637044385Daniel E Casey, David G Daniel, Carol Tamminga, John M Kane, Tram Tran-Johnson, Patricia Wozniak, Walid Abi-Saab, Jeff Baker, Laura Redden, Nicholas Greco, Mario Saltarelli

Neuropsychopharmacology, vol. 34, no. 5, pp. 1330-1338, 2009

(Citations:7)

]]>A Double-Blind Randomized Trial of Mood Stabilizer Augmentation Using Lamotrigine and Valproate for Patients With Schizophrenia Who Are Stabilized and Partially Responsivehttp://academic.research.microsoft.com/Publication/32842216Wed, 19 Jun 2013 13:28:22 GMT2386290632842216Ira D. Glick, Jeane Bosch, Daniel E. Casey

J CLIN PSYCHOPHARMACOL, vol. 29, no. 3, pp. 267-271, 2009

(Citations:6)

]]>ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementiahttp://academic.research.microsoft.com/Publication/37044138Wed, 19 Jun 2013 13:28:21 GMT2386290637044138Dilip V Jeste, Dan Blazer, Daniel Casey, Thomas Meeks, Carl Salzman, Lon Schneider, Pierre Tariot, Kristine Yaffe

Neuropsychopharmacology, vol. 33, no. 5, pp. 957-970, 2008

(Citations:35)

]]>Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding studyhttp://academic.research.microsoft.com/Publication/34721383Wed, 19 Jun 2013 13:28:20 GMT2386290634721383Daniel E. Casey, Earl E. Sands, Jens Heisterberg, Hwa-Ming Yang

Psychopharmacology, vol. 200, no. 3, pp. 317-331, 2008

(Citations:7)

]]>ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on Carotid Stenting: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting)http://academic.research.microsoft.com/Publication/30658267Wed, 19 Jun 2013 13:28:19 GMT2386290630658267E. R. Bates, C. J. D. Babb, D. E. Casey, C. U. Cates, G. R. Duckwiler, T. E. Feldman, W. A. Gray, K. Ouriel, E. D. Peterson, K. Rosenfield, J. H. Rundback, R. D. Safian, M. A. Sloan, C. J. White

VASC MED, vol. 12, no. 1, pp. 35-83, 2007

(Citations:56)

]]>Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents: A Science Advisory From the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, With Representation From the American College of Physicianshttp://academic.research.microsoft.com/Publication/33493981Wed, 19 Jun 2013 13:28:18 GMT2386290633493981C. L. Grines, R. O. Bonow, D. E. Casey, T. J. Gardner, P. B. Lockhart, D. J. Moliterno, P. O'Gara, P. Whitlow

Circulation, vol. 115, no. 6, pp. 813-818, 2007

(Citations:52)

]]>Comparison of Metabolic Syndrome Incidence Among Schizophrenia Patients Treated With Aripiprazole Versus Olanzapine or Placebohttp://academic.research.microsoft.com/Publication/39148018Wed, 19 Jun 2013 13:28:17 GMT2386290639148018Gilbert J. L'Italien, Daniel E. Casey

J CLIN PSYCHIAT, vol. 68, no. 10, pp. 1510-1516, 2007

(Citations:12)

]]>Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: The Physician Perspectivehttp://academic.research.microsoft.com/Publication/33498426Wed, 19 Jun 2013 13:28:16 GMT2386290633498426M. Sanz, R. W. Smalling, D. L. Brewer, W. J. French, L. A. Smaha, H. H. Ting, D. E. Casey

Circulation, vol. 116, no. 2, pp. e39-e42, 2007

(Citations:3)

]]>Schizophrenia and increased risks of cardiovascular diseasehttp://academic.research.microsoft.com/Publication/31127802Wed, 19 Jun 2013 13:28:15 GMT2386290631127802Charles H. Hennekens, Alissa R. Hennekens, Danielle Hollar, Daniel E. Casey

AMER HEART J, vol. 150, no. 6, pp. 1115-1121, 2005

(Citations:162)

]]>Metabolic issues and cardiovascular disease in patients with psychiatric disordershttp://academic.research.microsoft.com/Publication/24810562Wed, 19 Jun 2013 13:28:14 GMT2386290624810562Daniel E. Casey

American Journal of Medicine Supplement, vol. 118, pp. 15-22, 2005

(Citations:47)

]]>Antipsychotic drug-induced weight gain: development of an animal modelhttp://academic.research.microsoft.com/Publication/37064872Wed, 19 Jun 2013 13:28:13 GMT2386290637064872M B Cope, T R Nagy, J R Fernández, N Geary, D E Casey, D B Allison

INT J OBESITY, vol. 29, no. 6, pp. 607-614, 2005

(Citations:33)

]]>Physical Health Monitoring of Patients With Schizophreniahttp://academic.research.microsoft.com/Publication/10993114Wed, 19 Jun 2013 13:28:12 GMT2386290610993114Stephen R. Marder, Susan M. Essock, Alexander L. Miller, Robert W. Buchanan, Daniel E. Casey, John M. Davis, John M. Kane, Jeffrey A. Lieberman, Nina R. Schooler, Nancy Covell, D. Scott Stroup, M. P. H. Ellen, M. Weissman, M. P. H. Donna, A. Wirshing, M. D. Catherine, Leonard Pogach, Xavier Pi-Sunyer, M. P. H. J. Thomas, Alan Friedman, David Kleinberg, Steven J. Yevich, Bonnie Davis, Steven Shon

AMER J PSYCHIAT, vol. 161, no. 8, pp. 1334-1349, 2004

(Citations:261)

]]>Metabolic Effects of Treatment With Atypical Antipsychotics: (Commentary)http://academic.research.microsoft.com/Publication/39147271Wed, 19 Jun 2013 13:28:11 GMT2386290639147271John M. Kane, Eugene J. Barrett, Daniel E. Casey, Christoph U. Correll, Alan J. Gelenberg, Samuel Klein, John W. Newcomer

J CLIN PSYCHIAT, vol. 65, no. 11, pp. 1447-1455, 2004

(Citations:16)

]]>Metabolic Effects of Treatment With Atypical Antipsychoticshttp://academic.research.microsoft.com/Publication/14052429Wed, 19 Jun 2013 13:28:10 GMT2386290614052429John M. Kane, Eugene J. Barrett, Daniel E. Casey, Christoph U. Correll, Alan J. Gelenberg, Samuel Klein, John W. Newcomer

2004

(Citations:16)

]]>Reply: Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophreniahttp://academic.research.microsoft.com/Publication/37043093Wed, 19 Jun 2013 13:28:09 GMT2386290637043093Daniel E Casey, David G Daniel, Adel A Wassef, Katherine A Tracy, Patricia Wozniak, Kenneth W Sommerville

Neuropsychopharmacology, vol. 29, no. 3, pp. 637-638, 2004

]]>Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophreniahttp://academic.research.microsoft.com/Publication/37042767Wed, 19 Jun 2013 13:28:08 GMT2386290637042767Daniel E Casey, David G Daniel, Adel A Wassef, Katherine A Tracy, Patricia Wozniak, Kenneth W Sommerville

Neuropsychopharmacology, vol. 28, no. 1, pp. 182-192, 2003

(Citations:80)

]]>Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized studyhttp://academic.research.microsoft.com/Publication/48705953Wed, 19 Jun 2013 13:28:07 GMT2386290648705953Daniel E. Casey, William H. Carson, Anutosh R. Saha, Amy Liebeskind, Mirza W. Ali, Darlene Jody, Gary G. Ingenito

Psychopharmacology, vol. 166, no. 4, pp. 391-399, 2003

(Citations:33)

]]>DU127090: A novel partial dopamine agonist with antipsychotic activity behavioral effects of DU127090 in cebus non-human primateshttp://academic.research.microsoft.com/Publication/35812649Wed, 19 Jun 2013 13:28:06 GMT2386290635812649H. Yang, D. E. Casey, R. W. Feenstra, C. G. Kruse, S. K. Long

SCHIZOPHR RES, vol. 60, no. 1, pp. 370-370, 2003

(Citations:1)

]]>Effect of a Novel Potential Atypical Antipsychotic Drug, Y-931, in Producing Dystonia in Cebus Monkeyshttp://academic.research.microsoft.com/Publication/38714980Wed, 19 Jun 2013 13:28:05 GMT2386290638714980Yasuyuki Shiigi, Jun-ichi Maeda, Hiroshi Yasumatsu, Hiroshi Tanaka, Daniel E. Casey

J PHARMACOL SCI, vol. 93, no. 3, pp. 364-366, 2003

(Citations:1)

]]>The effect of atypical antipsychotic drugs in patients with preexisting diabeteshttp://academic.research.microsoft.com/Publication/35812621Wed, 19 Jun 2013 13:28:04 GMT2386290635812621J. L. Matchett, N. B. Fishman, S. B. Radmaker, D. E. Casey

SCHIZOPHR RES, vol. 60, no. 1, pp. 362-362, 2003

]]>Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophreniahttp://academic.research.microsoft.com/Publication/56650121Wed, 19 Jun 2013 13:28:03 GMT2386290656650121Daniel E Casey, David G Daniel, Adel A Wassef, Latherine A Tracy, Patricia Wozniak, Kenneth W Sommerville

Neuropsychopharmacology, vol. 28, no. 11, pp. 2052-2053, 2003

]]>Changes in body mass index for individuals with and without schizophrenia, 1987–1996http://academic.research.microsoft.com/Publication/35811629Wed, 19 Jun 2013 13:28:02 GMT2386290635811629Peter Homel, Daniel Casey, David B. Allison

SCHIZOPHR RES, vol. 55, no. 3, pp. 277-284, 2002

(Citations:51)

]]>A Multidose Study of Haloperidol Decanoate in the Maintenance Treatment of Schizophreniahttp://academic.research.microsoft.com/Publication/11159337Wed, 19 Jun 2013 13:28:01 GMT2386290611159337John M. Kane, John M. Davis, Nina Schooler, Stephen Marder, Daniel Casey, Benjamin Brauzer, Jim Mintz, D. Robert Conley

AMER J PSYCHIAT, vol. 159, no. 4, pp. 554-560, 2002

(Citations:16)

]]>Estimating the consequences of anti-psychotic induced weight gain on health and mortality ratehttp://academic.research.microsoft.com/Publication/35421983Wed, 19 Jun 2013 13:28:00 GMT2386290635421983Kevin R Fontaine, Moonseong Heo, Edmund P Harrigan, Charles L Shear, Mani Lakshminarayanan, Daniel E Casey, David B Allison

PSYCHIAT RES, vol. 101, no. 3, pp. 277-288, 2001

(Citations:83)

]]>Barriers to progress-the impact of tolerability problemshttp://academic.research.microsoft.com/Publication/37697104Wed, 19 Jun 2013 13:27:59 GMT2386290637697104Daniel E. Casey

INT CLIN PSYCHOPHARMACOL, vol. 16, no. Supplement, pp. S15-S19, 2001

(Citations:7)

]]>The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primateshttp://academic.research.microsoft.com/Publication/34719023Wed, 19 Jun 2013 13:27:58 GMT2386290634719023Daniel Casey, Jacques Bruhwyler, Jacques Delarge, Joseph Géczy, Jean-François Liégeois

Psychopharmacology, vol. 157, no. 3, pp. 228-235, 2001

(Citations:2)

]]>[Without Title]http://academic.research.microsoft.com/Publication/48496135Wed, 19 Jun 2013 13:27:57 GMT2386290648496135Daniel E. Casey, Jacques Bruhwyler, Jacques Delarge, Joseph Géczy, Jean-François Liégeois

Psychopharmacology, vol. 157, no. 3, pp. 228-235, 2001

]]>DU 127090: A highly potent, atypical dopamine receptor ligand — Behavioral effects of DU 127090 in Cebus non-human primateshttp://academic.research.microsoft.com/Publication/35626653Wed, 19 Jun 2013 13:27:56 GMT2386290635626653D. E. Casey, B. J. Van Vliet, R. Feenstra, C. G. Kruse, S. K. Long

EUR NEUROPSYCHOPHARMACOL, vol. 10, pp. 333-333, 2000

(Citations:2)

]]>Tardive dyskinesia and atypical antipsychotic drugshttp://academic.research.microsoft.com/Publication/35810385Wed, 19 Jun 2013 13:27:55 GMT2386290635810385Daniel E. Casey

SCHIZOPHR RES, vol. 35, pp. S61-S66, 1999

(Citations:48)

]]>The V89L Polymorphism in the 5a-Reductase Type 2 Gene and Risk of Prostate Cancer1http://academic.research.microsoft.com/Publication/6977887Wed, 19 Jun 2013 13:27:54 GMT238629066977887Phillip G. Febbo, Philip W. Kantoff, Elizabeth A. Platz, Daniel Casey, Steve Batter, Edward Giovannucci, Charles H. Hennekens, Meir J. Stampfer

1999

(Citations:23)

]]>Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primateshttp://academic.research.microsoft.com/Publication/34718403Wed, 19 Jun 2013 13:27:53 GMT2386290634718403Yasuyuki Shiigi, Daniel E. Casey

Psychopharmacology, vol. 146, no. 1, pp. 67-72, 1999

(Citations:13)

]]>Specific characteristics of EPS — implications for drug developmenthttp://academic.research.microsoft.com/Publication/35625615Wed, 19 Jun 2013 13:27:52 GMT2386290635625615D. E. Casey

EUR NEUROPSYCHOPHARMACOL, vol. 9, pp. 155-156, 1999

]]>A comparison of fixed-dose, intramuscular (IM) ziprasidone with flexible-dose, IM haloperidolhttp://academic.research.microsoft.com/Publication/35625133Wed, 19 Jun 2013 13:27:51 GMT2386290635625133R. H. Swift, E. P. Harrigan, D. van Kannnen, D. E. Casey

EUR NEUROPSYCHOPHARMACOL, vol. 8, pp. S216-S216, 1998

(Citations:1)

]]>Neuroleptic Intolerancehttp://academic.research.microsoft.com/Publication/49380906Wed, 19 Jun 2013 13:27:50 GMT2386290649380906Thomas E. Hansen, Daniel E. Casey, William F. Hoffman

SCHIZOPHRENIA BULL, vol. 23, no. 4, pp. 567-582, 1997

(Citations:27)

]]>Will the new antipsychotics bring hope of reducing the risk of developing extrapyramidal syndromes and tardive dyskinesia?http://academic.research.microsoft.com/Publication/37696604Wed, 19 Jun 2013 13:27:49 GMT2386290637696604Daniel E. Casey

INT CLIN PSYCHOPHARMACOL, vol. 12, pp. S19-S28, 1997

(Citations:11)

]]>Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeyshttp://academic.research.microsoft.com/Publication/34717217Wed, 19 Jun 2013 13:27:48 GMT2386290634717217Daniel E. Casey

Psychopharmacology, vol. 124, no. 1, pp. 134-140, 1996

(Citations:19)

]]>Movements in never-medicated schizophrenics: a preliminary studyhttp://academic.research.microsoft.com/Publication/34717190Wed, 19 Jun 2013 13:27:47 GMT2386290634717190D. S. Fenn, W. F. Hoffman, D. E. Casey, D. Moussaoui, N. Kadri, A. Tilane, B. Bentounssi, M. Khomeis

Psychopharmacology, vol. 123, no. 2, pp. 206-210, 1996

(Citations:17)

]]>Extrapyramidal Syndromes: Epidemiology, Pathophysiology and the Diagnostic Dilemmahttp://academic.research.microsoft.com/Publication/38911253Wed, 19 Jun 2013 13:27:46 GMT2386290638911253Daniel E. Casey

Cns Drugs, vol. 5, no. Supplement, pp. 1-12, 1996

(Citations:5)

]]>Choreoathetoid movements occur spontaneously in never-medicated patients with schizophreniahttp://academic.research.microsoft.com/Publication/35623304Wed, 19 Jun 2013 13:27:45 GMT2386290635623304W. Hoffman, N. Kadri, D. Fenn, A. Tilane, C. Green, M. Lakloumi, F. Bousaid, B. Bentounssi, D. Moussaoui, D. Casey

EUR NEUROPSYCHOPHARMACOL, vol. 6, pp. 223-223, 1996

(Citations:4)

]]>Drug Evaluations: Drug Evaluation Central & Peripheral Nervous Systems: ‘Seroquel’ (quetiapine): Preclinical and clinical findings of a new atypical antipsychotichttp://academic.research.microsoft.com/Publication/38800188Wed, 19 Jun 2013 13:27:44 GMT2386290638800188Daniel E Casey

EXPERT OPIN INVESTIG DRUGS, vol. 5, no. 8, pp. 939-957, 1996

(Citations:5)

]]>Comparative studies of abnormal involuntary movements in never-treated vs treated populations with schizophreniahttp://academic.research.microsoft.com/Publication/36018777Wed, 19 Jun 2013 13:27:43 GMT2386290636018777D. Moussaoui, D. Fenn, N. Kadri, C. Green, A. Tilane, B. Bentounsi, D. Casey, W. Hoffman

EUR PSYCHIAT, vol. 11, pp. 170s-170s, 1996

(Citations:1)

]]>A fifteen year follow-up study of tardive dyskinesia and drug induced Parkinsonismhttp://academic.research.microsoft.com/Publication/35622811Wed, 19 Jun 2013 13:27:42 GMT2386290635622811G. Gardos, D. E. Casey, A. Perenyi, J. D. Cole, E. Kocsis, J. A. Samson, W. Wycoff

EUR NEUROPSYCHOPHARMACOL, vol. 6, pp. 131-132, 1996

]]>Atypical neuroleptics in older monkeyshttp://academic.research.microsoft.com/Publication/35623383Wed, 19 Jun 2013 13:27:41 GMT2386290635623383Daniel E. Casey

EUR NEUROPSYCHOPHARMACOL, vol. 6, pp. 28-28, 1996

]]>Motor and mental aspects of extrapyramidal syndromeshttp://academic.research.microsoft.com/Publication/37696380Wed, 19 Jun 2013 13:27:40 GMT2386290637696380D E Casey

INT CLIN PSYCHOPHARMACOL, vol. 10, no. Supplement, pp. 105-114, 1995

(Citations:30)

]]>The effects of D 1 (NNC 22-0215) and D 2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeyshttp://academic.research.microsoft.com/Publication/34717081Wed, 19 Jun 2013 13:27:39 GMT2386290634717081D. E. Casey

Psychopharmacology, vol. 121, no. 3, pp. 289-293, 1995

(Citations:5)

]]>Mild tardive dystonia is common in chronic schizophrenicshttp://academic.research.microsoft.com/Publication/35807872Wed, 19 Jun 2013 13:27:38 GMT2386290635807872W. F. Hoffman, M. A. Bagdanoff, T. E. Hansen, G. A. Keepers, D. E. Casey

SCHIZOPHR RES, vol. 15, no. 1, pp. 208-208, 1995

]]>Motor and mental aspects of extrapyramidal syndromeshttp://academic.research.microsoft.com/Publication/37696381Wed, 19 Jun 2013 13:27:37 GMT2386290637696381D. E. Casey

INT CLIN PSYCHOPHARMACOL, vol. 10, pp. 105-114, 1995

]]>The role of dopamine receptor subtypes in nonhuman primate models of antipsychotic drug-induced movement disordershttp://academic.research.microsoft.com/Publication/35807863Wed, 19 Jun 2013 13:27:36 GMT2386290635807863Daniel E. Casey

SCHIZOPHR RES, vol. 15, no. 1, pp. 205-205, 1995

]]>S-2-2 Movement disorders in schizophrenia: Current considerationshttp://academic.research.microsoft.com/Publication/35621817Wed, 19 Jun 2013 13:27:35 GMT2386290635621817D. E. Casey

EUR NEUROPSYCHOPHARMACOL, vol. 5, no. 3, pp. 164-165, 1995

]]>Motor and mental aspects of acute extrapyramidal syndromeshttp://academic.research.microsoft.com/Publication/36824676Wed, 19 Jun 2013 13:27:34 GMT2386290636824676D. E. Casey

ACTA PSYCHIAT SCAND, vol. 89, no. s380, pp. 14-20, 1994

(Citations:35)

]]>Striking a balance between safety and efficacy: experience with the SSRI sertralinehttp://academic.research.microsoft.com/Publication/37696327Wed, 19 Jun 2013 13:27:33 GMT2386290637696327D. E. Casey

INT CLIN PSYCHOPHARMACOL, vol. 9, pp. 5-12, 1994

(Citations:3)

]]>Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primateshttp://academic.research.microsoft.com/Publication/34716445Wed, 19 Jun 2013 13:27:32 GMT2386290634716445Daniel E. Casey

Psychopharmacology, vol. 112, no. S1, pp. S55-S59, 1993

(Citations:22)

]]>Health insurance reform and the physician-patient relationshiphttp://academic.research.microsoft.com/Publication/28303531Wed, 19 Jun 2013 13:27:31 GMT2386290628303531D. E. Casey

JAMA-J AM MED ASSN, vol. 269, no. 19, pp. 2503b-2503, 1993

]]>Underrecognition of tardive dyskinesia and drug-induced parkinsonism by psychiatric residentshttp://academic.research.microsoft.com/Publication/29995584Wed, 19 Jun 2013 13:27:30 GMT2386290629995584Thomas E. Hansen, William L. Brown, Ronald M. Weigel, Daniel E. Casey

GEN HOSP PSYCHIAT, vol. 14, no. 5, pp. 340-344, 1992

(Citations:17)

]]>Dopamine D 1 (SCH 23390) and D 2 (haloperidol) antagonists in drug-naive monkeyshttp://academic.research.microsoft.com/Publication/34715989Wed, 19 Jun 2013 13:27:29 GMT2386290634715989Daniel E. Casey

Psychopharmacology, vol. 107, no. 1, pp. 18-22, 1992

(Citations:23)

]]>Effect of haloperidol and clozapine on the density of “perforated” synapses in caudate, nucleus accumbens, and medial prefrontal cortexhttp://academic.research.microsoft.com/Publication/34715867Wed, 19 Jun 2013 13:27:28 GMT2386290634715867Charles K. Meshul, Aaron Janowsky, Daniel E. Casey, Regina K. Stallbaumer, Barry Taylor

Psychopharmacology, vol. 106, no. 1, pp. 45-52, 1992

(Citations:27)

]]>Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesiahttp://academic.research.microsoft.com/Publication/35806188Wed, 19 Jun 2013 13:27:27 GMT2386290635806188Daniel E. Casey

SCHIZOPHR RES, vol. 4, no. 2, pp. 109-120, 1991

(Citations:60)

]]>Acute Extrapyramidal Syndromes in Neuroleptic-Treated Elders: A Pilot Studyhttp://academic.research.microsoft.com/Publication/28887251Wed, 19 Jun 2013 13:27:26 GMT2386290628887251Linda Ganzini, Ronald Heintz, William F. Hoffman, George A. Keepers, Daniel E. Casey

J GERIATR PSYCHIATR NEUROL, vol. 4, no. 4, pp. 222-225, 1991

(Citations:13)

]]>Neuropsychiatry of involuntary movement disorders. tardive dyskinesiahttp://academic.research.microsoft.com/Publication/37740746Wed, 19 Jun 2013 13:27:25 GMT2386290637740746Daniel E. Casey

CURR OPIN PSYCHIATRY, vol. 4, no. 1, pp. 86-89, 1991

]]>Lack of platelet monoamine oxidase activity in cebus monkeys (Cebus albifrons)http://academic.research.microsoft.com/Publication/34867560Wed, 19 Jun 2013 13:27:24 GMT2386290634867560Ron Heintz, Mary Ann Richardson, Autour S. Perumal, Daniel E. Casey

COMP BIOCHEM PHYSIOL C COMP PHARMACOL, vol. 93, no. 2, pp. 421-423, 1989

]]>Reply from Drs Keeper and Caseyhttp://academic.research.microsoft.com/Publication/32809289Wed, 19 Jun 2013 13:27:23 GMT2386290632809289George A. Keepers, Daniel E. Casey

J CLIN PSYCHOPHARMACOL, vol. 9, no. 4, 1989

]]>Prediction of Neuroleptic-Induced Dystoniahttp://academic.research.microsoft.com/Publication/32804598Wed, 19 Jun 2013 13:27:22 GMT2386290632804598GEORGE A. KEEPERS, DANIEL E. CASEY

J CLIN PSYCHOPHARMACOL, vol. 7, no. 5, 1987

(Citations:9)

]]>Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeyshttp://academic.research.microsoft.com/Publication/34714594Wed, 19 Jun 2013 13:27:21 GMT2386290634714594R. Heintz, D. E. Casey

Psychopharmacology, vol. 93, no. 2, pp. 207-213, 1987

(Citations:1)

]]>